There were 790 press releases posted in the last 24 hours and 167,007 in the last 365 days.

Innovative, Enthusiastic, and Patient Oriented Manufacturing Company Entering the US Neurodiagnostic Marketplace

Phelan and Mistretta (left to right) exhibiting at the 2018 ASNM Annual Meeting in Orlando, FL

An enthusiastic and patient oriented team is proud to announce the official launch of Spes Medica USA into the US Neurodiagnostic marketplace.

NEWBURYPORT, MASSACHUSETTS, UNITED STATES, March 7, 2018 / -- Patrick Phelan, President of Ives EEG Solutions, LLC, makers of the Ives Electrode System, and Matteo Mistretta, CEO of Spes Medica SRL are proud to announce the official launch of Spes Medica USA, a manufacturing company developing medical devices and accessories for Neurodiagnostics and Electrostimulation.

Mr. Phelan and Mr. Mistretta have been working tirelessly to create a joint partnership to meet their customers’ needs of affordable, high quality, innovative products for Intraoperative Neuromonitoring and Electroencephalography or EEG monitoring.

Patrick and Matteo combine for more than 30 years of experience and expertise in product innovation for the neurodiagnostic field. Ives EEG Solutions is best known for their MR Conditional electrodes for use in the ICU and during Long Term Monitoring in the EMU. Spes Medica is an Italian company that designs, tests and distributes a wide range of neurodiagnostic tools and accessories. Spes Medica has offices in 11 cities worldwide with manufacturing plants in three countries. Now for the first time their superior products will be entering the US market.

“This is an excellent opportunity for us to come together for one common goal” states Patrick Phelan, President of Spes Medica USA. “We are building premium products to improve the quality of diagnostic tests and to show continuous improvement and respect for the patient.” Matteo Mistretta, CEO of Spes Medica SRL echoes the same, “We are so pleased with the outcome of this partnership; I’m truly excited for the patients and technologists who will benefit the most. We are passionate about what we do and I’m looking forward to sharing our passion and products with the US market.”

The Spes Medica USA products will be manufactured in Italy and are FDA approved. The company headquarters will be located in Newburyport, Massachusetts, from where all products will be distributed.

Concurrently, Ives EEG Solutions and Spes Medica USA are pleased to announce the addition of Sarah Dolezilek as Marketing Manager. Dolezilek will be responsible for handling key strategic and tactical business development efforts for both companies.

“We are very proud to welcome Sarah to Ives and bring her on board at Spes Medica USA as well,” said Phelan. “We feel confident that she will provide us with the means to strategically build upon our new and existing business initiatives.”

Sarah joins the Ives and Spes Medica teams with more than eleven years of marketing experience in the neurodiagnostic field. She is particularly committed to the advancement of the neurodiagnostic profession. Most recently, she served as Marketing and Communications Manager for ASET, the national membership and professional development society for neurodiagnostic technologists. “I am excited for this new opportunity to engage with technologists and have a more direct impact on patient care,” says Dolezilek.

“Sarah shares the same values that we at Ives live and work by, above all is her commitment to our customers,” says Phelan, “customer service is paramount in her work ethic.”

Dolezilek holds a Bachelor of Science from Kansas State University in Manhattan, KS.

About Ives EEG Solutions
Ives designs and builds medical devices to permit clinicians and researchers to better diagnose and treat their patients. They are constantly exploring, and researching new techniques in the EEG field. Strong working relationships with their customers and constant improvements to their product are values they put first. They continue to listen to their customers and EEG Technologists around the world to offer the best product and solution possible. Their vision is to help advance EEG in every ICU and EMU around the globe.

Ives EEG Solutions was founded in 1995, developing both proprietary and OEM products for both EEG and Sleep. In 2001 they recognized the need for MR Conditional electrodes for cEEG/ICU and LTM/EMU, and changed their primary focus toward developing and manufacturing their proprietary MR Conditional Electrode System to address this demand. The Ives Electrode System is FDA approved, and they are pleased to be able to offer fully customized solutions to each institution.

About Spes Medica
Spes Medica is an Italian company manufacturing medical devices and accessories for Neurodiagnostics, Electrocardiography and Electrostimulation. They were founded in 1999 by Francesco Lisi. They design, test and distribute a wide range of electrodes and cooperate with organizations that are interested in the development of the know how. Their mission consists in manufacturing medical accessories by investing in quality and in a constant innovation research. Spes Medica philosophy is based on the will to innovate and realize avant-garde products characterized by originality and exclusivity and high tech.


Sarah Dolezilek
Spes Medica USA
email us here

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.